.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Clinical Advances and Challenges With Biosimilars

EP. 1: Payer Intervention and Biosimilar Switching

August 23rd 2017

EP. 2: Extrapolation of Indications in Biosimilars

August 23rd 2017

EP. 3: Cost and Biosimilars in Oncology

August 23rd 2017

EP. 4: Competition and Cost for Biosimilars

August 23rd 2017

EP. 5: Cost, Patient Programs, and Access to Biosimilars

August 23rd 2017

EP. 6: Naming and Coding of Biosimilars

August 23rd 2017

EP. 7: State Legislation on Biosimilars and Substitution

August 23rd 2017

EP. 8: Biosimilars in the Next 5 Years

August 23rd 2017